Regular Article
Genotype-dependent Down-regulation of Gene Expression and Function of MDR1 in Human Peripheral Blood Mononuclear Cells under Acute Inflammation

https://doi.org/10.2133/dmpk.21.194Get rights and content

Summary:

Recent advances in pharmacogenomics have suggested the association of clinical outcome of glucocorticoid-based anti-inflammatory therapy with a single nucleotide polymorphism at position 3435 in exon 26 (C3435T) of the MDR1 gene. In the present study, the effects of the MDR1 C3435T genotype on the time-dependent profiles of gene expression and function of MDR1/P-glycoprotein were evaluated in peripheral blood mononuclear cells (PBMCs) under lipopolysaccharide (LPS)-induced experimental acute inflammation. LPS treatment resulted in the rapid elevation of IL-1β and TNF-α mRNA levels relative to β-actin mRNA at 1 h, with a subsequent slight decrease at 3 h after the treatment, while the down-regulation of the relative concentration of MDR1 mRNA was found at 3 h, not at 1 h, after LPS treatment. Here, the C3435T genotype-dependent down-regulations of MDR1 mRNA level were found for CC3435 and CT3435, but not for TT3435, and were 64.1 ± 10.1%, 71.4 ± 5.9% and 100.0 ± 22.5% (± S.D.), respectively, of their respective baseline levels, which were independent of C3435T (0.010 ± 0.005, 0.011 ± 0.013 and 0.009 ± 0.006 (± S.D.), respectively). The C3435T genotype-dependent down-regulation was supported by the increase of the intracellular accumulation of calcein in PBMCs treated with LPS for 72 h, and the increase was more predominant for CC3435 than TT 3435. These data suggested that glucocorticoid-based anti-inflammatory therapy might be more effective for C 3435 -allele carriers than non-carriers.

References (32)

  • T. Sakaeda et al.

    Pharmacogenetics of drug transporters and its impact on the pharmacotherapy

    Curr. Top. Med. Chem.

    (2004)
  • T. Sakaeda et al.

    Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs

    Pharmacogenomics

    (2003)
  • C. Yates et al.

    Structural determinants of P-glycoprotein-mediated transport of glucocorticoids

    Pharm. Res.

    (2003)
  • T. Asano et al.

    ABCB1 C3435T and G2677T/ A polymorphism decreased the risk for steroid-induced osteonecrosis of the femoral head after kidney transplantation

    Pharmacogenetics

    (2003)
  • H.X. Zheng et al.

    The impact of pharmacogenomic factors on steroid dependency in pediatric heart transplant patients using logistic regression analysis

    Pediatr. Transplant.

    (2004)
  • A. Pawlik et al.

    The MDR1 3435 polymorphism in patients with rheumatoid arthritis

    Int. J. Clin. Pharmacol. Ther.

    (2004)
  • Cited by (20)

    • Association of ABCB1 gene polymorphisms and haplotypes with therapeutic efficacy of glucocorticoids in Chinese patients with immune thrombocytopenia

      2014, Human Immunology
      Citation Excerpt :

      It is widely accepted that genetic factors play a pivotal role in several aspects of ITP despite it is an autoimmune disorder, including susceptibility of this disease [17], and the response to GCs treatment varies from patient to patient [18]. Recently, three SNPs of ABCB1 (C1236T, C3435T and G2677T/A) were proved to be associated with GCs anti-inflammatory effects [19], glucocorticoid receptors [20] and related complications [21]. However, little is known about the roles of these SNPs and haplotypes in GCs curative effects during treatment of ITP.

    • Host genetic risk factors for community-acquired pneumonia

      2013, Gene
      Citation Excerpt :

      Although ABCB1 is a well-conserved gene, there is increasing evidence that its polymorphisms affect substrate specificity and may be the expression level and/or stability of its mRNA (Fung and Gottesman, 2009). For example, it has been shown that under experimental acute inflammation ABCB1 mRNA expression is significantly down-regulated in PBMCs (peripheral blood mononuclear cells) obtained from the subjects harboring 3435C in comparison to those without it (Markova et al., 2006). We therefore suggest that during inflammation the fast efflux of drugs in the subjects carrying 3435T/T genotype may contribute to the progression of the disease.

    • ABCB1 and ABCC1 expression in peripheral mononuclear cells is influenced by gene polymorphisms and atorvastatin treatment

      2009, Biochemical Pharmacology
      Citation Excerpt :

      Interestingly, the down regulation of the ABCB1 mRNA induced by atorvastatin seems to be dependent on G2677T/A polymorphism suggesting that this SNP plays an important role in regulating ABCB1 expression. On the other hand, reduction of ABCB1 mRNA levels in PBMC in response to lipopolysaccharide (LPS)-induced experimental acute inflammation was found to be associated with ABCB1 C3435T SNP [49]. Genetic factors as contributors to patient’s intervariability in lipid-lowering response to statins have been investigated in aspects of pharmacokinetics (e.g. ABC and SLC transporters, CYPs enzymes, UGT enzymes), pharmacodynamics (e.g. HMGCR, LDLR, CETP, APOA1, APOE, etc.) and disease-related genes (e.g. NOS3, ESR1, LOX-1) [reviewed in [20]].

    View all citing articles on Scopus
    View full text